Innovative Blood Resources, Division Of New York Blood Center, Inc. FDA Record
- Latest inspection NAI · May 11, 2022
- No warning letters matched by name
Innovative Blood Resources, Division Of New York Blood Center, Inc. has 0 FDA recalls, 6 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Innovative Blood Resources, Division Of New York Blood Center, Inc." is on file.
- Latest inspection
- May 11, 2022 · NAI
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 0 | Nov 15, 2026 | File dated Nov 10, 2026 | Current |
| 510(k) clearances | 0 | Nov 15, 2026 | File dated Nov 9, 2026 | Current |
| Inspections | 6 | Nov 17, 2026 | Newest record Nov 9, 2026 | Current |
| Compliance actions | 0 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
FDA record by year
Innovative Blood Resources, Division Of New York Blood Center, Inc.: FDA inspections per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 1 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 0 | 0 | 0 | 0 | 0 |
| 2018 | 0 | 0 | 0 | 0 | 0 |
| 2017 | 1 | 0 | 0 | 0 | 0 |
Reviewing Innovative Blood Resources, Division Of New York Blood Center, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Innovative Blood Resources, Division Of New York Blood Center, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| May 11, 2022 | Lincoln, NE | Biologics | No Action Indicated (NAI) | 3006339449 |
| Oct 26, 2017 | Lincoln, NE | Biologics | No Action Indicated (NAI) | 3006339449 |
| Feb 3, 2016 | Lincoln, NE | Biologics | No Action Indicated (NAI) | 3006339449 |
| Mar 12, 2014 | Lincoln, NE | Biologics | No Action Indicated (NAI) | 3006339449 |
| May 3, 2012 | Lincoln, NE | Biologics | No Action Indicated (NAI) | 3006339449 |
| Dec 3, 2009 | Lincoln, NE | Biologics | No Action Indicated (NAI) | 3006339449 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3006339449 | Lincoln, NE | 6 | May 11, 2022 |
Innovative Blood Resources, Division Of New York Blood Center, Inc. and the FDA: common questions
Has Innovative Blood Resources, Division Of New York Blood Center, Inc. received an FDA warning letter?
No FDA warning letter addressed to the name "Innovative Blood Resources, Division Of New York Blood Center, Inc." is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.
Has Innovative Blood Resources, Division Of New York Blood Center, Inc. received an FDA Form 483?
FDA has not published a Form 483 for "Innovative Blood Resources, Division Of New York Blood Center, Inc." in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Innovative Blood Resources, Division Of New York Blood Center, Inc.?
The most recent FDA inspection on file ended May 11, 2022 at Lincoln, NE and was classified NAI. FDA has 6 inspections of Innovative Blood Resources, Division Of New York Blood Center, Inc. on file.
Need more than this page shows? Ask about Innovative Blood Resources, Division Of New York Blood Center, Inc. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.